期刊文献+

丙酸氟替卡松对呼吸道上皮细胞基因表达的不同作用 被引量:2

Differential effects of fluticasone propionate(FP) on gene expression in airway epithelial cells
下载PDF
导出
摘要 目的呼吸道上皮细胞在固有免疫和炎症反应中都扮演重要角色。本文旨在研究强效吸入型糖皮质激素丙酸氟替卡松(FP)对双链RNA(dsRNA,Toll样受体3的配体)刺激的呼吸道粘膜上皮细胞BEAS-2B产生的某些固有免疫相关蛋白和炎性细胞因子的作用。方法FP(10-7mol.L-1)作用于BEAS-2B 2 h后,加入dsRNA 25 mg.L-1继续培养18 h,提取细胞RNA和收集细胞培养上清液。实时定量PCR测定炎性细胞因子IL-8、GM-CSF、IL-1β和固有免疫蛋白血清淀粉样蛋白(SAA)、补体B因子、分泌性白细胞蛋白酶抑制物(SLPI)的mRNA含量;ELISA分析上清液中IL-8、GM-CSF、SAA蛋白水平。结果BEAS-2B细胞在dsRNA刺激后,IL-8、GM-CSF、IL-1β、SAA、补体B因子、SLPI的mRNA均增高。FP预处理的细胞,在dsRNA刺激后,SAA、补体B因子、SLPI的mRNA水平不降低,IL-8、GM-CSF、IL-1β的mRNA水平明显降低。IL-8、GM-CSF、SAA的ELISA分析证实了mRNA的试验结果。结论FP在强效抗炎的同时,并不损伤呼吸道上皮局部的固有免疫。 Aim Airway epithelial cells play importam roles in innate immunity and inflammatory responses in the airways. We investigated the effect of the potent inhaled glucocorticoid FP on expressions of both innate immune effectors and inflammatory mediators in BEAS- 2B airway epithelial cells after stimulation with Tolllike receptor 3 ligand double stranded RNA (dsRNA). Methods BEAS-2B airway ted with FP ( 10^-7 mol · L^-1 )for 2h before stimulation with dsRNA (25 mg ·L^-1). RNA was isolated and the cell supernant was collected, mRNA for the inflammatory cytokines IL-8, GM-CSF, IL-1β and the innate immunity effectors serum amyloid A (SAA), complement B factor, secretory leukocyte protease inhibitor (SLPI) were quantified by real-time RT-PCR.The protein level of IL-8, GM-CSF and SAA in the su- pernant was analyzed by ELISA. Results Stimulation of BEAS-2B cells with dsRNA increased the mRNA levels of IL-8, GM-CSF, IL-Iβ, SAA, B factor and SLPI. Treatment with FP did not inhibit induction of mRNA for SAA, B factor and SLPI. FP did inhibit ex- pressions of mRNA for IL-8, GM-CSF, IL-1β. ELISA of IL-8, GM-CSF and SAA confirmed the mRNA expression results. Conclusion Our results suggest that FP may spare innate responses in airway epithelial cells while it inhibit expression of inflammatory mediators.
出处 《中国药理学通报》 CAS CSCD 北大核心 2006年第1期67-70,共4页 Chinese Pharmacological Bulletin
基金 美国国立卫生院(NIH)资助项目(NoHL48544 AI44885 AI50530) 安徽省优秀青年科技基金资助项目(No04043053)
关键词 吸入型糖皮质激素 丙酸氟替卡松 固有免疫 炎性细胞因子 呼吸道上皮细胞 inhaled glucocorticoids fluticasone propionate innate immunity inflammatory cytokines airway epithelial cells
  • 相关文献

参考文献15

  • 1Schleimer RP.Glucocorticoids.In Middleton E,Reed CE,Ellis EF,JNF,Adkinson,JW,Yunginger and W.Busse,editors.Allergy:Principles and Practice,6th edition[M].Mosby,St Louis,2003:870-87. 被引量:1
  • 2Jaffuel D,Demoly P,Gougat C et al.Transcriptional potencies of inhaled glucocorticoids[J].Am J Respir Crit Care Med,2000,162(1):57-63 被引量:1
  • 3Thompson PJ.Unique role of allergens and the epithelium in asthma[J].Clin Exp Allergy,1998,28(Suppl):110-16. 被引量:1
  • 4Takeda K,Kaisho T,Akira S.Toll-like receptors[J].Annul Rev Immunol,2003,21:335-76. 被引量:1
  • 5Sha Q,Truong-Tran AQ,Plitt JR et al.Activation of airway epithelial cells by toll-like receptor agonists[J].Am J Respir Cell Mol Biol,2004,31(3):358-64. 被引量:1
  • 6Reddel RR,Ke Y,Gerwin BI et al.Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus,or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes[J].Cancer Res,1988,48(7):1904-9. 被引量:1
  • 7何桦,郑劲平.吸入型糖皮质激素和吸入型长效β_2受体激动剂在COPD中的联合应用[J].国外医学(呼吸系统分册),2005,25(3):194-196. 被引量:44
  • 8Hari-Dass R,Shah C,Meyer DJ et al.Serum amyloid A protein binds to outer membrane protein A of Gram-negative bacteria[J].J Biol Chem,2005,280(19):18562-7. 被引量:1
  • 9Doumas S,Kolokotronis A,Stefanopoulos P.Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor[J].Infect Immun,2005,73(3):1271-4. 被引量:1
  • 10Ward PA,Lentsch AB.Endogenous regulation of the acute inflammatory response[J].Mol Cell Biochem,2002,234(1-2):225-8. 被引量:1

二级参考文献13

  • 1Pauwels RA,Buist AS,Calverley PM,et al.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease.NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.Am J Respir Crit Care Med,2001,163(5):1256-1276. 被引量:1
  • 2Kasahara Y,Tatsumi K,Kuriyama T.Chronic obstructive lung diseases Nippon Naika Gakkai Zasshi,2003,92(7):1218-1221 被引量:1
  • 3Jaffuel D,Demoly P,Gougat C,et al.Am J Respir Crit Care Med,2000,162(1):57-63. 被引量:1
  • 4Calverley PMA,Pauwels RA,Vestbo J,et al.Salmeterol/fluticasone propionate combination for one year provides greater clinical benefit than its individual components in COPD.Am J Respir Crit Care Med,2002,165(8):A226. 被引量:1
  • 5Vestbo J,Pauwels RA,Calverley PMA,et al.Salmeterol/fluticasone propionate combination produces improvement in lung function detectable within 24 hours in moderate to severe COPD.Am J Rspir Crit Care Med,2003,167(7):A89. 被引量:1
  • 6Hanania NA,Darken P,Horstman D.The efficacy and safety of fluticasone propionate(250microg)/salmeterol(50microg) combined in the Diskus inhaler for the treatment of COPD.Chest,2003,124(3):834-843. 被引量:1
  • 7Cazzola M,Di Lorenzo G,Di Perna F.Additive effects of salmeterol and fluticasone or theophylline in COPD.Chest,2000,118(6):1576-1581. 被引量:1
  • 8Pauwels RA,Vestbo J,Calverley PMA,et al.Characterisation of exacerbations in the TRISTAN study of salmeterol/fluticasone propionate combination in moderate to severe COPD.Am J Respir Crit Care Med,2003,167(7):A949. 被引量:1
  • 9Pauwels RA,Vestbo J,Calverley PMA,et al.Reduction of exacerbations with salmeterol/fluticasone combination 50/500mcg bd in the treatment of COPD.Eur Respir J,2002,20(Suppl 38):241s. 被引量:1
  • 10Soriano JB,Vestbo J,Pride NB.et al.Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice.Eur Respir J,2002,20(4):819-825. 被引量:1

共引文献43

同被引文献21

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部